Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 407, Issue 1-2, Pages 77-87Publisher
SPRINGER
DOI: 10.1007/s11010-015-2456-5
Keywords
Fluorofenidone; Fibrosis; JAK2/STAT3 pathway; Obstructive nephropathy; Diabetic nephropathy
Categories
Funding
- Doctoral Foundation of the Ministry of Education of China [20120162130001]
- National Natural Science Foundation of China [81273575]
- National Natural Science Foundation for Distinguished Young Scholars of China [81300610]
Ask authors/readers for more resources
Signaling through the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, especially JAK2/STAT3, is involved in renal fibrosis. Fluorofenidone (FD), a novel pyridone agent, exerts anti-fibrotic effects in vitro and in vivo. Herein, we sought to investigate whether FD demonstrates its inhibitory function through preventing JAK2/STAT3 pathway. In this study, we examined the effect of FD on activation of rat renal interstitial fibroblasts, glomerular mesangial cells (GMC), and expression of JAK2/STAT3. Moreover, we explored the histological protection effects of FD in UUO rats, db/db mice, and phosphorylation of JAK2/STAT3 cascade. Our studies found that pretreatment with FD resulted in blockade of activation of fibroblast and GMC manifested by fibronectin (FN) and alpha-smooth muscle actin (alpha-SMA) protein expression and decline of STAT3 tyrosine phosphorylation induced by IL-6 or high glucose. In unilateral ureteral obstruction rats and a murine model of spontaneous type 2 diabetes (db/db mice), treatment with FD blocked the expression of FN and alpha-SMA, prevented renal fibrosis progression, and attenuated STAT3 activation. However, FD administration did not interfere with JAK2 activation both in vivo and in vitro. In summary, the molecular mechanism by which FD exhibits renoprotective effects appears to involve the inhibition of STAT3 phosphorylation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available